Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

By Yahoo! Finance | Nov 7, 2024 at 02:38 AM EST

Terry Rosen, CEO, discussed the direct move to human studies without preclinical work with Fallu and CA. Atrumid program's next steps are being planned post ARC nine data. The strategy for IO-naive renal cell cancer setting is in collaboration with AstraZeneca.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.